kinase News
Most Popular kinase Story
Scripps Florida sees first biotech spinoff take root
Scripps Florida is heralding its first private spinoff, a tangible return on the investment the state has made in wooing research institutes to the state. Xcovery has licensed the lab work of Chris Liang with designs on new therapies for cancer and inflammation. Liang has concentrated much of his work on kinase inhibitors; finding ways to block the activity of enzymes that play a role in diseases like rheumatoid arthritis. Biocatalyst International has agreed to provide about a million …
... Read more...Latest Headlines
- November 21, 2007
- November 14, 2007
- January 8, 2007
- October 4, 2006
- January 26, 2006
- November 29, 2005
- October 24, 2005
- August 31, 2005
- August 9, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
